Investigation of the interleukin 1 gene cluster and its association with acute pancreatitis

Pancreas

Volumn 20, Issue 3, 2000, Pages 234-240

  Smithies, A M ^a   Sargen, K ^a   Demaine, A G ^a   Kingsnorth, Andres N ^a,b  

^a PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

Acute pancreatitis; Interleukin 1 (IL 1 ); Interleukin 1 receptor antagonist (IL 1ra); Polymorphism

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ALLELES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; FEMALE; GENE FREQUENCY; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MULTIGENE FAMILY; PANCREATITIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SIALOGLYCOPROTEINS;

EID: 0034023474     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200004000-00003     Document Type: Article

References (35)

1. Kingsnorth AN. Role of cytokines and their inhibitors in acute pancreatitis. Gut 1997;40:1-4.
2. Kingsnorth AN, Sargen K. The inflammatory response in acute pancreatitis. Curr Opin Crit Care 1998;4:121-4.
3. Scholmerich J. Interleukins in acute pancreatitis. Scand J Gastroenterol Suppl 1996;219:37-42.
4. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998;175:76-83.
5. Stuber F, Petersen M, Bokelmann F. A genomic polymorphism within the tumour necrosis factor locus influences plasma tumour necrosis factor alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 1996;24:381-4.
6. Lennard A, Gorman P, Carrier M, et al. Cloning and chromosome mapping of the human interleukin-1 receptor antagonist gene. Cytokine 1992;2:83-9.
7. Nicklin MJ, Weith A, Duff GW. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta and interleukin-1 receptor antagonist genes. Genomics 1994;19:382-4.
8. Haskill S, Martin G, Van Le L, et al. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc Natl Acad Sci U S A 1991;88:3681-5.
9. Thompson RC, Dripps DJ, Eisenberg SP. Interleukin-1 receptor antagonist (IL-1ra) as a probe and as a treatment for IL-1 mediated disease. Int J Immunopharmacol 1992;14:475-80.
10. Dinarello CA, Wolff SM. The role of Interleukin-1 in disease. N Engl J Med 1993;328:106-13.
11. Casini-Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease: a novel mechanism of chronic intestinal inflammation. J Immunol 1995;154:2434-40.
12. Norman J, Franz M, Riker A, et al. Rapid elevation of systemic cytokines during acute pancreatitis and their origination within the pancreas. Surg Forum 1994;45:148-50.
13. Norman J, Franz M, Messina J, et al. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1995;117:648-55.
14. Granowitz EV, Santos AA, Potsiaka DD, et al. Production of interleukin-1 receptor antagonist during experimental endotoxemia. Lancet 1991;338:1423-4.
15. Miller LC, Lynch EA, Isa S, Logan JW, Dinarello CA, Steere AC. Balance of synovial fluid IL-1beta and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 1993;341:146-8.
16. Firestein GS, Boyle DL, Yu C, et al. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 1994;37:644-52.
17. Rambaldi A, Torcia M, Bettoni S, et al. Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells. Blood 1991;78:3248-53.
18. Gruss HJ, Dolken G, Brach MA, Mertelsmann R, Herrmann F. High concentrations of the interleukin-1 receptor antagonist in serum of patients with Hodgkin's disease. Lancet 1992;340:968.
19. McDowell TL, Symons JA, Ploski R, Forre O, Duff GW. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum 1995;38:221-8.
20. Pociot F, Ronningen KS, Bergholdt R, et al. Genetic susceptibility markers in Danish patients with type I (insulin-dependent) diabetes: evidence for polygenicity in man: Danish Study Group of Diabetes in Childhood. Autoimmunity 1994;19:169-78.
21. Tarlow JK, Blakemore AI, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86 bp tandem repeat. Hum Genet 1993;91:403-4.
22. Tarlow JK, Cork MJ, Clay FE, et al. Association between the interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late onset psoriasis. Br J Dermatol 1997;136:147-8.
23. Blakemore AI, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 1994;37:1380-5.
24. Clay FE, Cork MJ, Tarlow JK, et al. Interleukin-1 receptor antagonist gene polymorphism association with lichen sclerosus. Hum Genet 1994;94:407-10.
25. Tarlow JK, Clay FE, Cork MJ, et al. Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 1994;103:387-90.
26. Blakemore AI, Cox A, Gonzalez AM, et al. Interleukin-1 receptor antagonist allele (IL1RN*2) is associated with nephropathy in diabetes mellitus. Hum Genet 1996;97:369-74.
27. Duerr RH, Tran T. Association between ulcerative colitis and a polymorphism in intron 2 of the interleukin-1 receptor antagonist gene. Gastroenterology 1995;108:A812.
28. Mansfield JC, Holden H, Tarlow JK, et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994;106: 637-42.
29. Tountas NA, Yang H, Coulter DL, et al. Increased carriage of allele 2 of IL-1 receptor antagonist (IL-1ra) in Jewish populations: the strongest known genetic association in ulcerative colitis. Gastroenterology 1996;110(Suppl):A1029.
30. Andus T, Daig R, Vogl, D et al. Imbalance of the interleukin 1 system in colonie mucosa-association with intestinal inflammation and IL-1ra [corrected] genotype 2. Gut 1997;41:651-7.
31. Blakemore AI, Watson PF, Weetman AP, Duff GW. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 1995;80:111-5.
32. de la Concha EG, Arroyo R, Crusius JB, et al. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis. J Neuroimmunol 1997;80:172-8.
33. Kingsnorth AN, Galloway SW, Formela LJ. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br J Surg 1995;82:1414-20.
34. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: intersubject variation and relationship to an IL-1 receptor antagonist (IL-1ra) gene polymorphism. Clin Exp Immunol 1995;99:303-10.
35. Mandrup-Poulsen T, Pociot F, Molvig J, et al. Monokine antagonism is reduced in patients with IDDM. Diabetes 1994;43:1242-7.